INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 141 filers reported holding INTERSECT ENT INC in Q3 2017. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,189,000 | -53.6% | 31,745 | -51.3% | 0.00% | -57.1% |
Q1 2018 | $2,562,000 | +82.2% | 65,200 | +50.3% | 0.01% | +133.3% |
Q4 2017 | $1,406,000 | +7.1% | 43,380 | +2.9% | 0.00% | -57.1% |
Q3 2017 | $1,313,000 | +29.1% | 42,160 | -21.2% | 0.01% | -22.2% |
Q1 2016 | $1,017,000 | -28.2% | 53,508 | -15.1% | 0.01% | 0.0% |
Q4 2015 | $1,417,000 | +48.5% | 62,990 | +54.6% | 0.01% | +50.0% |
Q3 2015 | $954,000 | -30.4% | 40,754 | -14.8% | 0.01% | -14.3% |
Q2 2015 | $1,370,000 | +76.3% | 47,860 | +59.0% | 0.01% | +75.0% |
Q1 2015 | $777,000 | – | 30,093 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |